Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial
- PMID: 26340411
- DOI: 10.1002/hep.28148
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial
Abstract
Bleeding is a feared complication of invasive procedures in patients with cirrhosis and significant coagulopathy (as defined by routine coagulation tests) and is used to justify preprocedure use of fresh frozen plasma (FFP) and/or platelets (PLT). Thromboelastography (TEG) provides a more comprehensive global coagulation assessment than routine tests (international normalized ratio [INR] and platelet count), and its use may avoid unnecessary blood product transfusion in patients with cirrhosis and significant coagulopathy (defined in this study as INR >1.8 and/or platelet count <50 × 10(9) /L) who will be undergoing an invasive procedure. Sixty patients were randomly allocated to TEG-guided transfusion strategy or standard of care (SOC; 1:1 TEG:SOC). The TEG group would receive FFP if the reaction time (r) was >40 min and/or PLT if maximum amplitude (MA) was <30 mm. All SOC patients received FFP and/or PLT per hospital guidelines. Endpoints were blood product use and bleeding complications. Baseline characteristics of the two groups were similar. Per protocol, all subjects in the SOC group received blood product transfusions versus 5 in the TEG group (100% vs. 16.7%; P < 0.0001). Sixteen SOC (53.3%) received FFP, 10 (33.3%) PLT, and 4 (13.3%) both FFP and PLT. In the TEG group, none received FFP alone (P < 0.0001 vs. SOC), 2 received PLT (6.7%; P = 0.009 vs. SOC), and 3 both FFP and PLT (not significant). Postprocedure bleeding occurred in only 1 patient (SOC group) after large-volume paracentesis.
Conclusions: In patients with cirrhosis and significant coagulopathy before invasive procedures, TEG-guided transfusion strategy leads to a significantly lower use of blood products compared to SOC (transfusion guided by INR and platelet count), without an increase in bleeding complications. Remarkably, even in patients with significant coagulopathy, postprocedure bleeding was rare, indicating that TEG thresholds should be reevaluated.
© 2015 by the American Association for the Study of Liver Diseases.
Comment in
-
Transfusing common sense instead of blood products into coagulation testing in patients with cirrhosis: Overtreatment ≠ safety.Hepatology. 2016 Feb;63(2):368-70. doi: 10.1002/hep.28291. Epub 2015 Dec 9. Hepatology. 2016. PMID: 26474059 No abstract available.
-
Reply.Hepatology. 2016 Aug;64(2):683-4. doi: 10.1002/hep.28335. Epub 2016 Jan 8. Hepatology. 2016. PMID: 26547626 No abstract available.
-
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy.Hepatology. 2016 Aug;64(2):682-3. doi: 10.1002/hep.28336. Epub 2016 Jan 5. Hepatology. 2016. PMID: 26547808 No abstract available.
-
Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?Hepatology. 2016 Sep;64(3):989-90. doi: 10.1002/hep.28426. Epub 2016 Feb 19. Hepatology. 2016. PMID: 26704886 No abstract available.
-
Reply.Hepatology. 2016 Sep;64(3):990-1. doi: 10.1002/hep.28427. Epub 2016 Feb 19. Hepatology. 2016. PMID: 26705089 No abstract available.
-
Reply.Hepatology. 2017 Feb;65(2):752-753. doi: 10.1002/hep.28833. Epub 2016 Nov 25. Hepatology. 2017. PMID: 27639187 No abstract available.
-
Do we need to correct coagulation abnormalities prophylactically in patients with cirrhosis undergoing invasive procedures? a dilemma.Hepatology. 2017 Feb;65(2):751-752. doi: 10.1002/hep.28830. Epub 2016 Oct 20. Hepatology. 2017. PMID: 27639261 No abstract available.
-
The risk of bleeding after invasive procedures in patients with cirrhosis with severe coagulopathy.Hepatology. 2017 Feb;65(2):751. doi: 10.1002/hep.28855. Epub 2016 Nov 15. Hepatology. 2017. PMID: 27667300 No abstract available.
-
Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.Hepatology. 2017 Apr;65(4):1413-1414. doi: 10.1002/hep.29061. Epub 2017 Feb 21. Hepatology. 2017. PMID: 28103639 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical